A Novel Echocardiographic Parameter to Identify Individuals Susceptible to Acute Mountain Sickness.
Jingbin Ke,Jie Yang,Chuan Liu,Zhexue Qin,Jihang Zhang,Jun Jin,Shiyong Yu,Hu Tan,Yuanqi Yang,Chen Zhang,Jiabei Li,Jie Yu,Shizhu Bian,Xiaohan Ding,Chunyan He,Fangzhengyuan Yuan,Jingdu Tian,Chun Li,Rongsheng Rao,Lan Huang
DOI: https://doi.org/10.1016/j.tmaid.2021.102166
IF: 20.441
2021-01-01
Travel Medicine and Infectious Disease
Abstract:Background: Acute mountain sickness (AMS) may cause life-threatening conditions. This study aimed to screen echocardiographic parameters at sea level (SL) to identify predictors of AMS development. Methods: Overall, 106 healthy men were recruited at SL and ascended to 4100 m within 7 days by bus. Basic characteristics, physiological data, and echocardiographic parameters were collected both at SL and 4100 m above SL. AMS was identified by 2018 Lake Louise Questionnaire Score. Results: After acute high altitude exposure (AHAE), 33 subjects were diagnosed with AMS and exhibited lower lateral mitral valve tissue motion annular displacement (MV TMADlateral) at SL than AMS-free subjects (13.09 vs. 13.89 mm, p = 0.022). MV TMADlateral at SL was significantly correlated with AMS occurrence (OR = 0.717, 95% CI: 0.534-0.964, p = 0.028). The MV TMADlateral<13.30-mm group showed over 4-fold risk for AMS development versus the MV TMADlateral >= 13.30-mm group. After AHAE, the MV TMADlateral<13.30-mm group had increased HR (64 vs. 74 bpm, p = 0.001) and right-ventricular myocardial performance index (0.54 vs. 0.69, p = 0.009) and decreased left ventricular global longitudinal strain (-21.50 vs. -20.23%, p = 0.002), tricuspid valve E/A ratio (2.11 vs. 1.89, p = 0.019), and MV E-wave deceleration time (169.60 vs. 156.90 ms, p = 0.035). Conclusion: MV TMADlateral at SL was a potential predictor of AMS occurrence and might be associated with differential alterations of ventricular systolic and diastolic functions in subjects with different MV TMADlateral levels at SL after AHAE.